14 DAY TRIAL // Besides its many other health benefits, aspirin is now being said to reduce cancer risk by as much as 22% in people who take it fairly regularly.
More precisely, researchers maintain that people between the ages of 55 and 74 have significantly lower chances of being affected by said condition should they agree to take just one aspirin on a monthly basis.
The Queen's University in Belfast researchers now stating that a monthly intake of aspirin prevents the development of potentially life-threatening tumors explain that, all things considered, this drug is particularly effective in terms of keeping head and neck cancer at bay.
Thus, said 22% reduction in one's risk of getting cancer refers to the two aforementioned types of cancer, Daily Mail informs us.
After learning that the people between the ages of 55 – 74 who take at least one aspiring per month have significantly lower chances of having cancerous tumors grow in their body, the scientists argued that aspirin could be said to function as a so-called chemopreventive agent.
For those unaware, a chemopreventive agent is a chemical compound used to inhibit, delay, or reverse carcinogenesis.
Still, the researchers did admit that further research on the matter at hand was mandatory, the same source says.
“Regular aspirin use has been linked to preventing a number of cancers, and if it is a particularly successful practice for warding off mouth cancer, it should act as a springboard for more research,” Dr. Nigel Carter, the current chief executive of the British Dental Health Foundation, reportedly commented on these findings.
Despite aspirin's efficiency in terms of helping people stay free of various types of cancer, scientists wish to warn that those who smoke, drink a tad too much alcohol and fail to eat properly have very little chances of benefiting from this drug.
A detailed account of this research and its findings was published in the British Journal of Cancer.